G Protein-Coupled Estrogen Receptor Mediates Cell Proliferation through the cAMP/PKA/CREB Pathway in Murine Bone Marrow Mesenchymal Stem Cells

Rutin promotes osteogenic differentiation of periodontal ligament stem cells through the GPR30-mediated PI3K/AKT/mTOR signaling pathway

(2020) Bin Zhao et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

G protein-coupled estrogen receptor 1 negatively regulates the proliferation of mouse-derived neural stem/progenitor cells via extracellular signal-regulated kinase pathway

(2019) Jun Zhong et al.   BRAIN RESEARCH

Activation of GPR30 promotes osteogenic differentiation of MC3T3‐E1 cells: An implication in osteoporosis

(2019) Xiaozong Lin et al.   IUBMB LIFE

Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway

(2019) F. Yang et al.   Scientific Reports

Effects of the selective GPER-1 agonist G1 on bone growth

(2019) Maryam Iravani et al.   Endocrine Connections

17β-estradiol differently affects osteogenic differentiation of mesenchymal stem/stromal cells from adipose tissue and bone marrow

(2016) Stefania Niada et al.   DIFFERENTIATION

GPR30 Promotes Prostate Stromal Cell Activation via Suppression of ERα Expression and Its Downstream Signaling Pathway

(2016) Bona Jia et al.   ENDOCRINOLOGY

Not lost in translation: Emerging clinical importance of the G protein-coupled estrogen receptor GPER

(2016) Matthias Barton   STEROIDS

Estrogen receptor mediates simvastatin-stimulated osteogenic effects in bone marrow mesenchymal stem cells

(2015) Shu-Chun Chuang et al.   BIOCHEMICAL PHARMACOLOGY

Effects of Atrazine on Estrogen Receptor α– and G Protein–Coupled Receptor 30–Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts

(2015) Lidia Albanito et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation

(2014) P Daniel et al.   Oncogenesis

G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells

(2013) Li-Yuan Bai et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Functional Impairment of Bone Formation in the Pathogenesis of Osteoporosis: The Bone Marrow Regenerative Competence

(2013) Joseph P. Bidwell et al.   Current Osteoporosis Reports

The G Protein–Coupled Receptor GPR30 Mediates the Nontranscriptional Effect of Estrogen on the Activation of PI3K/Akt Pathway in Endometrial Cancer Cells

(2012) Xin Ge et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Estrogen receptor-α is required for the osteogenic response to mechanical loading in a ligand-independent manner involving its activation function 1 but not 2

(2012) Sara H Windahl et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Parathyroid hormone signaling via Gαs is selectively inhibited by an NH2-terminally truncated Gαs: Implications for pseudohypoparathyroidism

(2011) Svetlana Puzhko et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The GPER1 Agonist G-1 Attenuates Endothelial Cell Proliferation by Inhibiting DNA Synthesis and Accumulating Cells in the S and G2 Phases of the Cell Cycle

(2011) Anders Holm et al.   JOURNAL OF VASCULAR RESEARCH

Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction

(2011) Angelina Wallacides et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells

(2010) E. A. Ariazi et al.   CANCER RESEARCH

GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice

(2010) Jeffery Ford et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Update on Estrogens and the Skeleton

(2010) Sundeep Khosla   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures

(2009) Tomoko Minamizaki et al.   BONE

Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation

(2009) Benjamin C. Lin et al.   CANCER RESEARCH

The unfolding stories of GPR30, a new membrane-bound estrogen receptor

(2009) Marcello Maggiolini et al.   JOURNAL OF ENDOCRINOLOGY

Mechanisms of estrogen signaling and gene expression via GPR30

(2009) Eric R. Prossnitz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

GPR30/GPER1: searching for a role in estrogen physiology

(2009) Björn Olde et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Deletion of the G Protein-Coupled Receptor 30 Impairs Glucose Tolerance, Reduces Bone Growth, Increases Blood Pressure, and Eliminates Estradiol-Stimulated Insulin Release in Female Mice

(2008) Ulrika E. A. Mårtensson et al.   ENDOCRINOLOGY

Runx2 Regulates G Protein-coupled Signaling Pathways to Control Growth of Osteoblast Progenitors

(2008) Nadiya M. Teplyuk et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Simvastatin induces estrogen receptor-alpha (ER-α) in murine bone marrow stromal cells

(2008) Chunli Song et al.   JOURNAL OF BONE AND MINERAL METABOLISM

The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone

(2008) Terhi J Heino et al.   JOURNAL OF ENDOCRINOLOGY